Clinical Trials Logo

Anal Canal Cancer clinical trials

View clinical trials related to Anal Canal Cancer.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05060471 Enrolling by invitation - Anal Cancer Clinical Trials

PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients

Start date: September 8, 2021
Phase: Phase 2
Study type: Interventional

Locally Advanced Anal Canal Squamous Carcinoma Patients will be enrolled and given four cycles of neoadjuvant PD-1 antibody toripalimab combined with docetaxol and cisplatin, followed by radiotherapy and two cycles of concurrent toripalimab. Treatment outcomes and toxicities will be evaluated.